share_log

Sorrento Therapeutics | 5: Annual statement of changes in beneficial ownership of securities-Director Janda Kim

SEC ·  Feb 7, 2023 10:10
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.